Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.
Pharmaceut Med
; 35(4): 197-202, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1293483
ABSTRACT
The medical affairs function represents one of the scientific interfaces in a pharmaceutical organization. Over the last two decades, medical affairs has evolved from being a support function to a strategic pillar within organizational business units. The COVID-19 pandemic has given rise to unforeseen circumstances resulting in a dramatic change in external stakeholder engagements, catapulting the medical affairs function into leading the way on scientific engagements and patient-centric endeavors. The changes in stakeholder interactions and behavior as a result of the pandemic last year are likely to persist in the foreseeable future for which medical affairs professionals need to enhance existing skill sets and acquire expertise in newer domains. In this paper, the transformation of the medical affairs team to a key strategic partner and the skills required to strengthen this transition, in the next normal of a post-COVID world, is explored.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Drug Industry
/
Stakeholder Participation
/
Drug Development
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Pharmaceut Med
Year:
2021
Document Type:
Article
Affiliation country:
S40290-021-00392-x
Similar
MEDLINE
...
LILACS
LIS